論文・総説 - 原田　浩之

分割表示  499 件中 241 - 260 件目  ／  全件表示 >>

  1. Takahashi Y, Tanaka K, Hirai H, Marukawa E, Izumo T, Harada H. Appropriate surgical margin for odontogenic myxoma: a review of 12 cases. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. 2018.11; 126 (5): 404-408. ( DOI )

  2. Yamada S, Itai S, Furusawa Y, Sano M, NakamuraT, Yanaka M, Handa S, Hisamatsu K, Nakamura Y, Fukui M, Harada H, Mizuno T, Sakai Y, Ogasawara S, Murata T, Uchida H, Tahara H, Kaneko MK, Kato Y. Detection of tiger podoplanin using the anti-cat podoplanin monoclonal antibody PMab-52 Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 2018.11; 37 (5): 224-228. ( PubMed, DOI )

  3. Furusawa Y, Yamada S, Itai S, Sano M, Nakamura T, Yanaka M, Handa S, Mizuno T, Maeda K, Fukui M, Harada H, Kaneko MK, Kato Y. Establishment of Monoclonal Antibody PMab-202 against Horse Podoplanin Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 2018.11; 37 (5): 233-237. ( PubMed, DOI )

  4. Mochizuki Y, Harada H, Yokokawa M, Kinoshita N, Kubota K, Okado T, Fukayama H. Oral and maxillofacial surgery in patients undergoing dialysis for advanced renal disease: report of five cases. BMC Oral Health. 2018.10; 18 (1): 166-175. ( PubMed, DOI )

  5. Ngamsom S, Nakamura S, Kabasawa Y, Harada H, Tohyama R, Kurabayashi T. Imaging findings of intraosseous traumatic neuroma of the mandible Oral radiology. 2018.09; 34 (3): 257-261. ( DOI )

  6. Itai S, Yamada S, Kaneko MK, Sano M, Nakamura T, Yanaka M, Handa S, Hisamatsu K, Nakamura Y, Furusawa Y, Fukui M, Ohishi T, Kawada M, Harada H, Kato Y. Podocalyxin is crucial for the growth of oral squamous cell carcinoma cell line HSC-2 Biochem Biophys Rep. 2018.09; 15 93-96. ( PubMed, DOI )

  7. Kaneko MK, Yamada S, Itai S, Furusawa S, Nakamura T, Yanaka M, Handa S, Hisamatsu K, Nakamura Y, Fukui M, Harada H, Kato Y. Epitope mapping of an anti-alpha thalassemia/mental retardation syndrome Xlinked monoclonal antibody AMab-6 Biochem Biophys Rep. 2018.09; 15 76-80. ( PubMed, DOI )

  8. Yamada I, Yoshino N, Hikishima K, Sakamoto J, Yokokawa M, Oikawa Y, Harada H, Kurabayashi T, Saida Y, Tateishi U, Yukimori A, Izumo T, Asahina S. Oral carcinoma: Clinical evaluation using diffusion kurtosis imaging and its correlation with histopathologic findings Magnetic Resonance Imaging. 2018.09; 51 69-78. ( PubMed, DOI )

  9. Ngamsom Supak, Nakamura Shin, Kabasawa Yuji, Harada Hiroyuki, Tohyama Rei, Kurabayashi Tohru. 下顎骨内に発生した外傷性神経腫の画像所見(Imaging findings of intraosseous traumatic neuroma of the mandible) Oral Radiology. 2018.09; 34 (3): 257-261. ( 医中誌 )

  10. Ngamsom S, Nakamura S, Kabasawa Y, Harada H, Tohyama R, Kurabayashi T. Imaging findings of intraosseous traumatic neuroma of the mandible. Oral radiology. 2018.09; 34 (3): 257-261. ( PubMed, DOI )

  11. Matsui T, Okada T, Kawada K, Okuda m, Ogo T, Nakajima Y, Kume Y, Ryotokuji T, Hoshino A, Tokairin Y, Michi Y, Harada H, Nakajima Y, Kawano T. Detection of second primary malignancies of the esophagus and hypophraynx in oral squamous cell carcinoma patients Laryngoscope Investigative Otolaryngology. 2018.08; 3 (4): 263-267. ( DOI )

  12. Yamaga E, Toriihara A, Nakamura S, Asai S, Fujioka T, Yoshimura R, Michi Y, Harada H, Tateishi U. Clinical usefulness of 2-deoxy-2-[18F] fluoro-D-glucose-positron emission tomography/computed tomography for assessing early oral squamous cell carcinoma (cT1-2N0M0) Japanese Journal of Clinical Oncology. 2018.07; 48 (7): 633-639. ( DOI )

  13. Shimada Y, Kawasaki Y, Tayama M, Kindaichi J, Maruoka Y. A case of central odontogenic fibroma of the mandible in a nevoid basal cell carcinoma syndrome patient Oral Science International. 2018.07; 15 (2): 61-67. ( DOI )

  14. Yamaga Emi, Toriihara Akira, Nakamura Shin, Asai Sakurako, Fujioka Tomoyuki, Yoshimura Ryoichi, Michi Yasuyuki, Harada Hiroyuki, Tateishi Ukihide. 2-deoxy-2-[18F]fluoro-D-glucoseを用いたPET/CTによる早期口腔扁平上皮癌(cT1-2N0M0)評価の臨床有用性(Clinical usefulness of 2-deoxy-2-[18F] fluoro-D-glucose-positron emission tomography/computed tomography for assessing early oral squamous cell carcinoma(cT1-2NOMO)) Japanese Journal of Clinical Oncology. 2018.07; 48 (7): 633-639. ( 医中誌 )

  15. Yamada S, Kaneko MK, Itai S, Chang YW, Nakamura T, Yanaka M, Ogasawara S, Murata T, Uchida H, Tahara H, Harada H, Kato Y. Epitope Mapping of Monoclonal Antibody PMab-48 against Dog Podoplanin. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 2018.06; 37 (3): 162-165. ( PubMed, DOI )

  16. Ohata Y, Kayamori K, Yukimori A, Sumikura K, Ohsako T, Harada H, Sakamoto K, Ikeda T. A lesion categorized between ghost cell odontogenic carcinoma and dentinogenic ghost cell tumor with CTNNB1 mutation. Pathology International. 2018.05; 68 (5): 307-312. ( PubMed, DOI )

  17. Miyazaki H, Ohshiro T, Romeo U, Noguchi T, Maruoka Y, Gaimari G, Tomov G, Wada Y, Tanaka K, Ohshiro T, Asamura S. Retrospective Study on Laser Treatment of Oral Vascular Lesions Using the "Leopard Technique": The Multiple Spot Irradiation Technique with a Single-Pulsed Wave Photomed Laser Surgery. 2018.05; 36 (6): 320-325. ( PubMed )

  18. Furusawa Y, Yamada Y, Itai S, Nakamura T, Fukui M, Harada H, Kaneko MK, Kato Y. Elucidation of critical epitope mapping of anti-rat podoplanin monoclonal antibody PMab-2 Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 2018.05; 37 (4): 188-193. ( PubMed, DOI )

  19. Kaneko MK, Yamada S, Itai S, Chang YW, Nakamura T, Yanaka M, Harada H, Suzuki H, Kato Y. Elucidation of The TMab-6 Monoclonal Antibody Epitope Against Telomerase Reverse Transcriptase. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 2018.05; 38 (3): 101-103. ( PubMed, DOI )

  20. Ohata Yae, Kayamori Kou, Yukimori Akane, Sumikura Kanako, Ohsako Toshimitsu, Harada Hiroyuki, Sakamoto Kei, Ikeda Tohru. CTNNB1変異を伴う幻影細胞性歯原性癌と象牙質形成性幻影細胞腫間に分類された病変(A lesion categorized between ghost cell odontogenic carcinoma and dentinogenic ghost cell tumor with CTNNB1 mutation) Pathology International. 2018.05; 68 (5): 307-312. ( 医中誌 )

< 前のページ - 次のページ >

このページの先頭へ▲